You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III locally advanced unresectable non-small-cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • +2 more
  • standard Radiotherapy
  • +3 more
  • (no location specified)
Oct 20, 2023

Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

Completed
  • Non-small Cell Lung Cancer
  • Calgary, Alberta, Canada
  • +4 more
Jun 28, 2023

NSCLC Stage III, EGFR Positive NSCLC, Non-squamous Non-small-cell Lung Cancer Trial in Korea, Republic of (Lazertinib)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • +2 more
  • Busan, Korea, Republic of
  • +12 more
Jan 17, 2023

NSCLC Stage III Trial in Hefei (Envafolimab)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • Hefei, Anhui, China
    Anhui Provincial Cancer Hospital
Jun 8, 2022

Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Neoadjuvant therapy
  • +4 more
  • Foshan, Guangdong, China
  • +2 more
Oct 25, 2022

NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • San José, Costa Rica
  • +3 more
Aug 4, 2022

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes

Recruiting
  • Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
    • Grozny, Russian Federation
    • +4 more
    May 31, 2023

    Lung Cancer, Stage III Lung Cancer, Unresectable Lung Carcinoma Trial in Barcelona (procedure, diagnostic test, drug)

    Recruiting
    • Lung Cancer
    • +2 more
    • Sample collection
    • +3 more
    • Barcelona, Spain
      Parc de Salut Mar - Hospital del Mar
    Dec 8, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Stage III Locally Advanced Unresectable Non-small-cell Lung

    Not yet recruiting
    • Non-small Cell Lung Cancer Stage III
    • biomarker detection
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Feb 7, 2021

    NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)

    Not yet recruiting
    • NSCLC, Stage III
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    May 23, 2022

    Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Lung Non-Small Cell Carcinoma
    • +9 more
    • Biopsy
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Aug 2, 2022

    NSCLC Stage III Trial in Guangzhou (CS1001 mAb, CS1001 )

    Active, not recruiting
    • Non-Small Cell Lung Cancer Stage III
    • CS1001 monoclonal antibody
    • CS1001 placebo
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Jan 20, 2022

    Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

    Recruiting
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • +12 more
    • Computed Tomography
    • Contrast Agent
    • New Brunswick, New Jersey
    • +1 more
    Nov 2, 2022

    Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Columbus

    Recruiting
    • Locally Advanced Lung Non-Small Cell Carcinoma
    • +8 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 18, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +129 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Apr 8, 2022

    Predicting the Efficacy of Immunotherapy in Stage III NSCLC

    Recruiting
    • Stage III Non-small Cell Lung Cancer
    • CT
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Nov 6, 2021

    Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • carboplatin chemotherapy
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Nov 3, 2023

    Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

    Terminated
    • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
    • +9 more
    • Bintrafusp Alfa
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 4, 2022

    AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

    Recruiting
    • AIDS-Related Non-Hodgkin Lymphoma
    • +29 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Birmingham, Alabama
    • +12 more
    Aug 4, 2022

    Localized Lung Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Carcinoma Trial in United States

    Suspended
    • Localized Lung Carcinoma
    • +10 more
    • Accelerated Hypofractionated Radiation Therapy
    • +2 more
    • Atlanta, Georgia
    • +55 more
    Jan 10, 2023

    Stage III Non-small-cell Lung Cancer Trial in China (TQB2450, Anlotinib, TQB2450(blank))

    Recruiting
    • Stage III Non-small-cell Lung Cancer
    • Hefei, Anhui, China
    • +35 more
    Mar 15, 2022

    NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sugemalimab and Chemotherapy
    • Changsha, China
      Hunan Cancer Hospital
    Jul 7, 2023